Clinical Trial Update: A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MRG003 for EGFR-positive advanced/metastatic biliary tract cancer; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• MRG003

Snippet

Sponsor: Shanghai Miracogen Inc. | Conditions: Advanced or Metastatic Biliary Tract Cancer | Phase 2 | Status: UNKNOWN